Who Paid My Doc
Patrick Angelos
Facial Plastic Surgery Charleston, SC Medical Doctor
NPI 1487857272 CMS profile 67440
2295 Henry Tecklenburg Dr, Charleston, SC 29414
General payments
$615
Research payments
$0
Ownership & investment interest
$157,550
Through program year 2025, Patrick Angelos of Charleston, SC is reported in the CMS Open Payments database as having received $615 across 12 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $157,550 across 5 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 33rd percentile of Facial Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
11 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $274 | 4 | |
| 2024 | General | $136 | 4 | |
| 2023 | General | $29 | 1 | |
| 2021 | General | $15 | 1 | |
| 2020 | General | $119 | 1 | |
| 2019 | General | $42 | 1 | |
| 2025 | Ownership | $32,760 | 1 | |
| 2024 | Ownership | $32,129 | 1 | |
| 2023 | Ownership | $31,504 | 1 | |
| 2022 | Ownership | $30,885 | 1 | |
| 2021 | Ownership | $30,272 | 1 |
Beside peers
- Patrick Angelos
- Facial Plastic Surgery median
- Middle half of Facial Plastic Surgery
- National median
In program year 2025, general payments to Patrick Angelos were reported at $274. Among 437 Facial Plastic Surgery profiles paid that year, the median was $270 and the middle half received between $116 and $579.
Show as a table
| Year | Patrick Angelos | Facial Plastic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $42 | $225 | $92–$651 | $163 |
| 2020 | $119 | $132 | $45–$323 | $114 |
| 2021 | $15 | $186 | $67–$558 | $132 |
| 2022 | $0 | $218 | $83–$594 | $149 |
| 2023 | $29 | $237 | $94–$564 | $160 |
| 2024 | $136 | $233 | $104–$575 | $164 |
| 2025 | $274 | $270 | $116–$579 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 11 drugsPart D claims
332
Drug cost
$4,439
Branded share of claims
13.6%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Azelastine Hcl | Generic | 121 | $2,460 | |
| Ipratropium Bromide | Generic | 17 | $712 | |
| Fluticasone Propionate | Generic | 42 | $499 | |
| Cefdinir | Generic | 14 | $218 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 17 | $143 | |
| Montelukast Sodium | Generic | 17 | $94 | |
| Prednisone | Generic | 49 | $87 | |
| Omeprazole | Generic | 12 | $82 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 16 | $66 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 12 | $48 |
The 10 drugs with the highest cost, of 11 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,296 Part D prescribers listed as Otolaryngology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 74 billing codesPaid by Medicare
$125,955
Medicare patients
815
Services billed
2,537
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 69% | |
| Arthritis | 53% | |
| Ischemic heart disease | 24% | |
| Depression | 24% | |
| Osteoporosis | 22% | |
| Diabetes | 20% | |
| Chronic kidney disease | 17% | |
| Cancer | 16% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
12 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Facial Plastic Surgery in South Carolina
William Wells
Facial Plastic Surgery · Lexington, SC
David Rodwell
Facial Plastic Surgery · Charleston, SC
Daniel Boxwell
Facial Plastic Surgery · Seneca, SC
Krishna Patel
Facial Plastic Surgery · Charleston, SC
John Rich
Facial Plastic Surgery · Columbia, SC
Sam Meshkinfam
Facial Plastic Surgery · Florence, SC
Related records
Facial Plastic Surgery in South Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Facial Plastic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in South Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.